VERAMED, OOO, Moscow

Economic indicators

Net profit (RAS) of VERAMED, OOO grew over 2023 88.15 times to 1.76 million RUB from 20.00 thousand RUB over 2022, the company informed.

Revenue increased in the accounting period 3.64 times to 70.93 million RUB from 19.47 million RUB over 2022.

Net profit (RAS) of VERAMED, OOO dropped in 2022 75.55 times to 20.00 thousand RUB from 1.51 million RUB over the same period in 2021, the company informed.

Revenue decreased in the accounting period 3.94 times to 19.47 million RUB from 76.70 million RUB in 2021.

Net profit (RAS) of VERAMED, OOO dropped in 2021 81.98 times to 1.51 million RUB from 123.87 million RUB over the same period in 2020, the company informed.

Revenue decreased in the accounting period 11.51 times to 76.70 million RUB from 883.04 million RUB in 2020; cost of goods sold decreased 11.74 times to 58.07 million RUB from 681.61 million RUB; sales profit fell 129.55 times to 1.23 million RUB from 159.47 million RUB.

Net profit (RAS) of VERAMED, OOO grew over 2020 4.56 times to 123.87 million RUB from 27.19 million RUB over 2019, the company informed.

Revenue increased in the accounting period 5.15 times to 883.04 million RUB from 171.51 million RUB over 2019; cost of goods sold grew 5.61 times to 681.61 million RUB from 121.48 million RUB; sales profit went up 4.44 times to 159.47 million RUB from 35.88 million RUB.

Net profit (RAS) of VERAMED, OOO grew over 2019 3.22 times to 27.19 million RUB from 8.43 million RUB over 2018, the company informed.

Revenue increased in the accounting period 2.24 times to 171.51 million RUB from 76.67 million RUB over 2018; cost of goods sold grew 1.91 times to 121.48 million RUB from 63.70 million RUB; sales profit went up 3.32 times to 35.88 million RUB from 10.81 million RUB.

Companies in the region

• LAYSA
• BLEK FG
• INKOM SU-9
• ETALON
• EVALON